April 23, 2020 / 6:08 AM / a month ago

BRIEF-Alligator Bioscience Q1 Operating Loss Narrows To SEK 44.9 Mln

April 23 (Reuters) - Alligator Bioscience AB:

* ALLIGATOR BIOSCIENCE AB (PUBL) INTERIM REPORT JANUARY-MARCH 2020

* JANUARY-MARCH OPERATING RESULT, SEK -44.9 MILLION (-46.2)

* ON CORONAVIRUS: COVID-19 PANDEMIC IMPACTS RECRUITMENT OF NEW PATIENTS TO COMPANY’S ONGOING PHASE CLINICAL I STUDIES WITH ATOR-1015 AND ATOR-1017 DRUG CANDIDATES Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below